Skip to main content
Premium Trial:

Request an Annual Quote

BioCapital Invests $2.5 Million in Bioinformatics And Genomics Firms

Premium

MONTREAL--BioCapital Investments, a fixed capital investment limited partnership here that invests in healthcare and biotechnology companies with high growth potential, announced earlier this month that it invested $12.9 million in nine companies, including one bioinformatics company and one genomics firm.

The partnership invested $500,000 in Quantum Biotechnolo gies, a private company specializing in design and development of specific niche molecular and cellular manipulation products for the genomic research market. The core technologies of the company, already partly owned by BioCapital, are in molecular biology, molecular genetics and immunology.

Base4 Bioinformatics, which applies bioinformatics techniques to predict the function and utility of newly discovered human genes and proteins, received $2 million from partners Tera Capital Working Ventures and Allelix Biopharmaceuticals.

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.